| Style | Citing Format |
|---|---|
| MLA | Saffarian Z, et al.. "Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients." Dermatologic Therapy, vol. 35, no. 11, 2022, pp. -. |
| APA | Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H (2022). Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients. Dermatologic Therapy, 35(11), -. |
| Chicago | Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H. "Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients." Dermatologic Therapy 35, no. 11 (2022): -. |
| Harvard | Saffarian Z et al. (2022) 'Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients', Dermatologic Therapy, 35(11), pp. -. |
| Vancouver | Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H. Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients. Dermatologic Therapy. 2022;35(11):-. |
| BibTex | @article{ author = {Saffarian Z and Samii R and Hadizadeh A and Ghanadan A and Vahidnezhad H}, title = {Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients}, journal = {Dermatologic Therapy}, volume = {35}, number = {11}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Saffarian Z AU - Samii R AU - Hadizadeh A AU - Ghanadan A AU - Vahidnezhad H TI - Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients JO - Dermatologic Therapy VL - 35 IS - 11 SP - EP - PY - 2022 ER - |